• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

掌腱膜挛缩症中的基质和细胞表型差异

Matrix and cell phenotype differences in Dupuytren's disease.

作者信息

van Beuge Marike M, Ten Dam Evert-Jan P M, Werker Paul M N, Bank Ruud A

机构信息

Department of Pathology & Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.

Department of Pathology & Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands ; Department of Plastic Surgery, Department of Pathology & Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.

出版信息

Fibrogenesis Tissue Repair. 2016 Jun 29;9:9. doi: 10.1186/s13069-016-0046-0. eCollection 2016.

DOI:10.1186/s13069-016-0046-0
PMID:27366208
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4928329/
Abstract

BACKGROUND

Dupuytren's disease is a fibroproliferative disease of the hand and fingers, which usually manifests as two different phenotypes within the same patient. The disease first causes a nodule in the palm of the hand, while later, a cord develops, causing contracture of the fingers.

RESULTS

We set out to characterize the two phenotypes by comparing matched cord and nodule tissue from ten Dupuytren's patients. We found that nodule tissue contained more proliferating cells, CD68-positive macrophages and α-smooth muscle actin (α-SMA)-positive myofibroblastic cells. qPCR analysis showed an increased expression of COL1A1, COL1A2, COL5A1, and COL6A1 in nodule tissue compared to cord tissue. Immunohistochemistry showed less deposition of collagen type I in nodules, although they contained more fibronectin, collagen type V, and procollagen 1. Lower collagen levels in nodule were confirmed by HPLC measurements of the Hyp/Pro ratio. PCOLCE2, an activator of BMP1, the main enzyme cleaving the C-terminal pro-peptide from procollagen, was also reduced in nodule. Cord tissue not only contained more collagen I, but also higher levels of hydroxylysylpyridinoline and lysylpyridinoline residues per triple helix, indicating more crosslinks.

CONCLUSIONS

Our results clearly show that in Dupuytren's disease, the nodule is the active disease unit, although it does not have the highest collagen protein levels. The difference in collagen type I deposition compared to mRNA levels and procollagen 1 levels may be connected to a decrease in procollagen processing.

摘要

背景

杜普伊特伦挛缩病是一种手部和手指的纤维增生性疾病,通常在同一患者体内表现为两种不同的表型。该病首先在手掌形成一个结节,随后形成条索,导致手指挛缩。

结果

我们通过比较10例杜普伊特伦挛缩病患者匹配的条索和结节组织来表征这两种表型。我们发现结节组织含有更多的增殖细胞、CD68阳性巨噬细胞和α平滑肌肌动蛋白(α-SMA)阳性肌成纤维细胞。qPCR分析显示,与条索组织相比,结节组织中COL1A1、COL1A2、COL5A1和COL6A1的表达增加。免疫组织化学显示结节中I型胶原蛋白的沉积较少,尽管它们含有更多的纤连蛋白、V型胶原蛋白和前胶原蛋白1。通过HPLC测量Hyp/Pro比值证实结节中的胶原蛋白水平较低。PCOLCE2是BMP1的激活剂,BMP1是从前胶原蛋白切割C末端前肽的主要酶,在结节中也减少。条索组织不仅含有更多的I型胶原蛋白,而且每条三螺旋中羟赖氨酸吡啶啉和赖氨酸吡啶啉残基的水平也更高,表明交联更多。

结论

我们的结果清楚地表明,在杜普伊特伦挛缩病中,结节是活跃的疾病单位,尽管它的胶原蛋白蛋白水平不是最高的。I型胶原蛋白沉积与mRNA水平和前胶原蛋白1水平的差异可能与前胶原蛋白加工减少有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e848/4928329/f41ee96f5866/13069_2016_46_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e848/4928329/07f22d819850/13069_2016_46_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e848/4928329/be906a677068/13069_2016_46_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e848/4928329/1b7e8a41c8ef/13069_2016_46_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e848/4928329/c3a2405468cf/13069_2016_46_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e848/4928329/a484592b2200/13069_2016_46_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e848/4928329/f41ee96f5866/13069_2016_46_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e848/4928329/07f22d819850/13069_2016_46_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e848/4928329/be906a677068/13069_2016_46_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e848/4928329/1b7e8a41c8ef/13069_2016_46_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e848/4928329/c3a2405468cf/13069_2016_46_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e848/4928329/a484592b2200/13069_2016_46_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e848/4928329/f41ee96f5866/13069_2016_46_Fig6_HTML.jpg

相似文献

1
Matrix and cell phenotype differences in Dupuytren's disease.掌腱膜挛缩症中的基质和细胞表型差异
Fibrogenesis Tissue Repair. 2016 Jun 29;9:9. doi: 10.1186/s13069-016-0046-0. eCollection 2016.
2
Dupuytren's disease: physiologic changes in nodule and cord fibroblasts through aging in vitro.杜普伊特伦挛缩症:体外老化过程中结节和条索状成纤维细胞的生理变化
Plast Reconstr Surg. 2002 Jul;110(1):187-93; discussion 194-6. doi: 10.1097/00006534-200207000-00031.
3
Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.基质金属蛋白酶及其抑制剂在杜普伊特伦氏挛缩症患者的 cords 和 nodules 中的表达。
Arch Orthop Trauma Surg. 2009 Nov;129(11):1453-9. doi: 10.1007/s00402-008-0726-3. Epub 2008 Aug 30.
4
Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.来自杜普伊特伦氏结节或条索的成纤维细胞之间α平滑肌肌动蛋白表达的差异。
Exp Mol Pathol. 2001 Oct;71(2):147-55. doi: 10.1006/exmp.2001.2385.
5
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.掌腱膜挛缩症患者血清和组织中的基质金属蛋白酶及金属蛋白酶组织抑制剂
Plast Reconstr Surg. 2003 Oct;112(5):1279-86. doi: 10.1097/01.PRS.0000081462.40448.49.
6
Dupuytren's disease. A model for the mechanism of fibrosis and its modulation by steroids.杜普伊特伦挛缩症。纤维化机制及其受类固醇调节的模型。
J Bone Joint Surg Br. 1999 Jul;81(4):732-8. doi: 10.1302/0301-620x.81b4.9163.
7
Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.杜普伊特伦挛缩病成纤维细胞中α-平滑肌肌动蛋白表达与收缩的相关性
J Hand Surg Am. 1995 May;20(3):450-5. doi: 10.1016/S0363-5023(05)80105-4.
8
Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial.抗肿瘤坏死因子疗法治疗杜普伊特伦挛缩症:一项随机剂量反应概念验证 2a 期临床试验。
EBioMedicine. 2018 Jul;33:282-288. doi: 10.1016/j.ebiom.2018.06.022. Epub 2018 Jul 6.
9
Appearance of the myofibroblastic phenotype in Dupuytren's disease is associated with a fibronectin, laminin, collagen type IV and tenascin extracellular matrix.在掌腱膜挛缩症中,肌成纤维细胞表型的出现与纤连蛋白、层粘连蛋白、IV型胶原和腱生蛋白细胞外基质有关。
Pathobiology. 1994;62(2):55-8. doi: 10.1159/000163879.
10
Further evidence of the involvement of the Wnt signaling pathway in Dupuytren's disease.Wnt信号通路参与掌腱膜挛缩症的进一步证据。
J Cell Commun Signal. 2016 Mar;10(1):33-40. doi: 10.1007/s12079-015-0312-8. Epub 2015 Dec 3.

引用本文的文献

1
Active synthesis of type I collagen homotrimer in Dupuytren's fibrosis is unaffected by anti-TNF-α treatment.在杜普伊特伦挛缩症纤维化中,I型胶原同三聚体的活性合成不受抗TNF-α治疗的影响。
JCI Insight. 2025 May 8;10(9). doi: 10.1172/jci.insight.175188.
2
PCPE2: Expression of multifunctional extracellular glycoprotein associated with diverse cellular functions.PCPE2:与多种细胞功能相关的多功能细胞外糖蛋白的表达。
J Lipid Res. 2024 Nov;65(11):100664. doi: 10.1016/j.jlr.2024.100664. Epub 2024 Oct 5.
3
Alterations in the Structure, Composition, and Organization of Galactosaminoglycan-Containing Proteoglycans and Collagen Correspond to the Progressive Stages of Dupuytren's Disease.

本文引用的文献

1
Wnt pathway in Dupuytren disease: connecting profibrotic signals.掌腱膜挛缩症中的Wnt信号通路:连接促纤维化信号
Transl Res. 2015 Dec;166(6):762-771.e3. doi: 10.1016/j.trsl.2015.09.006. Epub 2015 Sep 25.
2
Clinical outcomes following collagenase injections compared to fasciectomy in the treatment of Dupuytren's contracture.与筋膜切除术相比,胶原酶注射治疗掌腱膜挛缩症后的临床疗效。
Hand (N Y). 2015 Jun;10(2):260-5. doi: 10.1007/s11552-014-9704-0.
3
The procollagen N-proteinases ADAMTS2, 3 and 14 in pathophysiology.原胶原蛋白 N 蛋白水解酶 ADAMTS2、3 和 14 在病理生理学中的作用。
半乳糖胺聚糖蛋白聚糖和胶原蛋白的结构、组成和组织的改变与进行性杜普伊特伦挛缩病的阶段相对应。
Int J Mol Sci. 2024 Jun 29;25(13):7192. doi: 10.3390/ijms25137192.
4
RNA-seq unravels distinct expression profiles of keloids and Dupuytren's disease.RNA测序揭示了瘢痕疙瘩和掌腱膜挛缩症不同的表达谱。
Heliyon. 2023 Dec 13;10(1):e23681. doi: 10.1016/j.heliyon.2023.e23681. eCollection 2024 Jan 15.
5
The Role of Functional Polymorphisms in the Extracellular Matrix Modulation-Related Genes on Dupuytren's Contracture.功能性多态性在外泌体基质调节相关基因在杜普伊特伦挛缩中的作用。
Genes (Basel). 2022 Apr 23;13(5):743. doi: 10.3390/genes13050743.
6
External Screw-Threaded Traction Device Helps Optimize Finger Joint Mobility in Severe Stage III and IV Dupuytren Disease.外螺纹牵引装置有助于优化严重 III 期和 IV 期杜普伊特伦病手指关节的活动度。
Med Sci Monit. 2021 Apr 22;27:e929814. doi: 10.12659/MSM.929814.
7
Attenuation of Dupuytren's fibrosis via targeting of the STAT1 modulated IL-13Rα1 response.通过靶向信号转导和转录激活因子1(STAT1)调节的白细胞介素-13受体α1(IL-13Rα1)反应减轻杜普伊特伦挛缩症的纤维化
Sci Adv. 2020 Jul 10;6(28):eaaz8272. doi: 10.1126/sciadv.aaz8272. eCollection 2020 Jul.
8
Single cell force profiling of human myofibroblasts reveals a biophysical spectrum of cell states.单细胞力谱分析揭示了人肌成纤维细胞的生物物理状态谱。
Biol Open. 2020 Mar 24;9(3):bio049809. doi: 10.1242/bio.049809.
9
Recent advances in the understanding of Dupuytren's disease.对掌腱膜挛缩症认识的最新进展。
F1000Res. 2019 Feb 28;8. doi: 10.12688/f1000research.17779.1. eCollection 2019.
Matrix Biol. 2015 May-Jul;44-46:46-53. doi: 10.1016/j.matbio.2015.04.001. Epub 2015 Apr 8.
4
BMP-1/tolloid-like proteinases synchronize matrix assembly with growth factor activation to promote morphogenesis and tissue remodeling.BMP-1/类 tolloid 蛋白酶通过同步基质组装与生长因子激活来促进形态发生和组织重塑。
Matrix Biol. 2015 May-Jul;44-46:14-23. doi: 10.1016/j.matbio.2015.02.006. Epub 2015 Feb 18.
5
Fibronectin at select sites binds multiple growth factors and enhances their activity: expansion of the collaborative ECM-GF paradigm.特定部位的纤连蛋白结合多种生长因子并增强其活性:细胞外基质-生长因子协作范例的扩展。
J Invest Dermatol. 2014 Apr;134(4):895-901. doi: 10.1038/jid.2013.484. Epub 2013 Dec 12.
6
A systematic review and meta-analysis on the prevalence of Dupuytren disease in the general population of Western countries.一项针对西方国家普通人群中 Dupuytren 病患病率的系统评价和荟萃分析。
Plast Reconstr Surg. 2014 Mar;133(3):593-603. doi: 10.1097/01.prs.0000438455.37604.0f.
7
Human amniotic fluid-derived mesenchymal cells from fetuses with a neural tube defect do not deposit collagen type i protein after TGF-β1 stimulation in vitro.人羊膜间充质干细胞来源于神经管缺陷胎儿,在 TGF-β1 刺激下,细胞在体外不分泌Ⅰ型胶原蛋白。
Stem Cells Dev. 2014 Mar 1;23(5):555-62. doi: 10.1089/scd.2013.0334. Epub 2013 Dec 6.
8
Novel combination of collagen dynamics analysis and transcriptional profiling reveals fibrosis-relevant genes and pathways.新型胶原动力学分析与转录谱分析相结合揭示了与纤维化相关的基因和通路。
Matrix Biol. 2013 Oct-Nov;32(7-8):424-31. doi: 10.1016/j.matbio.2013.04.005. Epub 2013 May 3.
9
Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target.解析促进杜普伊特伦挛缩症纤维化的信号通路揭示 TNF 作为治疗靶点。
Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):E928-37. doi: 10.1073/pnas.1301100110. Epub 2013 Feb 19.
10
Therapy for fibrotic diseases: nearing the starting line.纤维化疾病的治疗:即将起跑。
Sci Transl Med. 2013 Jan 9;5(167):167sr1. doi: 10.1126/scitranslmed.3004700.